Focus: Biogenes Technologies is a Malaysia-based molecular diagnostics and genomics company focused on diagnostic innovation. Limited public data suggests a specialized player in the diagnostics segment.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Biogenes Technologies to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
Help build intelligence for Biogenes Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Biogenes Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Recovery of hyaluronic acid using thermosensitive polymer-salt aqueous biphasic system with polymer recycling.
Aptamer-Based Detection of Foot-and-Mouth Disease Virus Using Single-Stranded DNA Probe.
Aptamer based immunotherapy: a potential solid tumor therapeutic.
Investigating the Diagnostic and Therapeutic Potential of a T Cell Receptor (TCR)-like single Domain Antibody (sDAb)-Human IgG1 Antibody against Heat Shock Protein (HSP) 16KDa/HLA-A2 for Latent Tuberculosis.
Purification of lipase from Burkholderia metallica fermentation broth in a column chromatography using polymer impregnated resins.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo